Cost-effective proactive testing strategies during COVID-19 mass vaccination: A modelling study.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Author
Du, ZhanweiWang, Lin
Bai, Yuan
Wang, Xutong
Pandey, Abhishek
Fitzpatrick, Meagan C
Chinazzi, Matteo
Pastore y Piontti, Ana
Hupert, Nathaniel
Lachmann, Michael
Vespignani, Alessandro
Galvani, Alison P
Cowling, Benjamin J
Meyers, Lauren Ancel
Date
2022-01-15Journal
Lancet Regional Health. AmericasPublisher
ElsevierType
Article
Metadata
Show full item recordAbstract
Assuming a willingness-to-pay of US$100,000 per averted year of life lost (YLL) and a price of $10 per test, the optimal strategy under a rapid transmission scenario (Re ∼ 2.5) is daily testing until one third of the population is immunized and then weekly testing until half the population is immunized, combined with a 10-day isolation period of positive cases and their households. Under a low transmission scenario (Re ∼ 1.2), the optimal sequence is weekly testing until the population reaches 10% partial immunity, followed by monthly testing until 20% partial immunity, and no testing thereafter.Rights/Terms
© 2022 The Author(s).Identifier to cite or link to this item
http://hdl.handle.net/10713/17791ae974a485f413a2113503eed53cd6c53
10.1016/j.lana.2021.100182